RPS Biologiques receives Health Canada notifications for latest fish health product  

Emergence client RPS Biologiques Inc. is pleased to announce that its latest Veterinary Health Product (VHP), Puralyze™, recently received two notification numbers from Health Canada’s Veterinary Drugs Directorate (VDD). Puralyze™ received approval in both liquid and powdered forms allowing this novel natural product to be marketed and sold in Canada. 

RPS Biologiques develops innovative biotech products with proven market potential. In 2019, the company’s natural product Supratect™ became the first VHP notified by Health Canada for use in aquatic species; an exceptional milestone that paved the way for future technologies to further enrich the  aquaculture industry with new, innovative products.

Read full story on the RPS Biologiques website.

This entry was posted in Uncategorized. Bookmark the permalink.